NCT06854406View on ClinicalTrials.gov

A Study of Varenicline in the Treatment of Visceral Sensation

PHASE1RecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Varenicline

Initial, 0.5 mg orally once daily for 3 days, then 0.5 mg every 12 hours on days 4 through 7, and then 1 mg in morning of day 8. Medication is taken after eating and with a full glass of water.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06854406 - A Study of Varenicline in the Treatment of Visceral Sensation | Biotech Hunter | Biotech Hunter